ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 292 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $286,000 | -34.3% | 4,309 | -38.2% | 0.00% | 0.0% |
| Q3 2021 | $435,000 | -55.8% | 6,967 | -41.4% | 0.00% | -50.0% |
| Q2 2021 | $984,000 | +42.4% | 11,882 | +14.0% | 0.00% | 0.0% |
| Q1 2021 | $691,000 | -24.8% | 10,425 | -13.0% | 0.00% | 0.0% |
| Q4 2020 | $919,000 | +184.5% | 11,982 | +59.8% | 0.00% | +100.0% |
| Q3 2020 | $323,000 | -50.5% | 7,499 | -50.4% | 0.00% | -50.0% |
| Q2 2020 | $653,000 | -66.6% | 15,127 | -77.7% | 0.00% | -81.8% |
| Q1 2020 | $1,954,000 | -78.6% | 67,923 | -52.9% | 0.01% | -76.6% |
| Q4 2019 | $9,138,000 | +86.0% | 144,067 | -17.4% | 0.05% | +56.7% |
| Q3 2019 | $4,914,000 | – | 174,380 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |